Metabolic syndrome in adults who received hematopoietic stem cell … – Nature.com
|
Metabolic syndrome in adults who received hematopoietic stem cell …
Nature.com We evaluated prospectively the incidence and risk factors of the metabolic syndrome (MS) and its components in 170 adult patients (mean age at evaluation: 24.8±5.4 years) who received an hematopoietic stem cell transplantation for childhood ALL, n=119, … |
|
Metabolic syndrome in adults who received hematopoietic stem cell …
Nature.com We evaluated prospectively the incidence and risk factors of the metabolic syndrome (MS) and its components in 170 adult patients (mean age at evaluation: 24.8±5.4 years) who received an hematopoietic stem cell transplantation for childhood ALL, n=119, … |
|
Stem Cells Show Promise as Type 2 Diabetes Treatment – Medscape
Medscape By targeting inflammation, adult allogeneic bone-marrow–derived mesenchymal precursor cells (MPCs) may represent a novel treatment for type 2 diabetes, a new pilot study suggests. Findings from the multicenter dose-escalating randomized … |
|
Stem Cells Show Promise as Type 2 Diabetes Treatment – Medscape
Medscape By targeting inflammation, adult allogeneic bone-marrow–derived mesenchymal precursor cells (MPCs) may represent a novel treatment for type 2 diabetes, a new pilot study suggests. Findings from the multicenter dose-escalating randomized … |
CBC.ca |
Frustrated former patients question probes into controversial stem–cell researcher
CBC.ca Former patients of a controversial Winnipeg-based stem–cell research company are growing increasingly frustrated by what they say is a lack of action by Canadian authorities. “I cannot believe that the authorities in Canada have not taken this seriously. |